Stock Evaluator: Mobile-health Network Solutions (MNDR)
Mobile-health Network Solutions MNDR
$1.67
-0.07
-4.02%
August 21, 2026 4:00:00 PM
EST
Volume: 46,742
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Mobile-health Network Solutions, an investment holding company, provides telehealth solutions primarily in Singapore. The company operates in two segments: Telemedicine and Other Services and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website, as well as Internet search engines. The company also provides a suite of medical-related and other services, including teleconsultations and health check-up services, vaccinations, skin and aesthetics services, and other services. In addition, it offers healthcare and wellness products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics through MaNaPharma platform; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical services. Additionally, it offers health supplements, skincare, nutrition products and medical devices wellness, personal care; health screening packages; and online services such as medical screenings and procedures, such as serology and swab tests. The company was founded in 2009 and is headquartered in Singapore.
Financial Summary
| Share Statistics | MNDR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.0 | $1,968.0 | 1% |
|
| Shares Out (Mil) | 0.2 | 77.7 | 1% |
|
| Institutional Ownership | 5.4% | 86.6% | 5% |
|
| Float (Mil) | 0.6 | 52.1 | 1% |
|
| Beta | -0.94 | 0.75 | 1% |
|
| Avg Daily Volume (000s) | 479 | 612 | 57% |
|
| Price Change (52-week) |
(94.7%) | 79.8% | 3% |
|
| Growth | MNDR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.9% | na |
|
| Net Income (5yr) | na | (1.6%) | na |
|
| EPS (5yr) | na | 0.3% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.9%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | MNDR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $8 | $1,504 | 8% |
|
| Net Income (TTM) (Mil) | ($3) | $28 | 35% |
|
| EPS (TTM) | ($22.920) | $0.200 | 2% |
|
| Operating Cash Flow (TTM) (Mil) | ($4) | $162 | 26% |
|
| Net Cash Flow (TTM) (Mil) | na | $9 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $338 | 0% |
|
| Enterprise Value (Q1) (Mil) | $4 | $2,416 | 5% |
|
| Valuation | MNDR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.11 | 2.82 | 1% |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | MNDR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 19.7% | 27.8% | 21% |
|
| Net Margin | (35.3%) | 1.2% | 14% |
|
| ROA | (85.8%) | 2.2% | 6% |
|
| ROE | (300.8%) | 7.2% | 3% |
|
| Liabilities to Assets | 41.2% | 58.6% | 32% |
|
| F-Score | 3 | 5 | 18% |
|
Mobile-health Network Solutions did not pass any screens on 8/21/2026.
